Suppression of growth and tumorigenicity in the prostate tumor cell line M12 by overexpression of the transcription factor SOX9

Oncogene

Volumn 23, Issue 26, 2004, Pages 4584-4593

  Drivdahl, Rolf ^a,b   Haugk, Kathy H ^a   Sprenger, Cynthia C ^b   Nelson, Peter S ^b,c   Tennant, Marie K ^b   Plymate, Stephen R ^a,b,d  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Androgens; Cancer; IGF; Prostate; SOX9

Indexed keywords

RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG; ANDROGEN RECEPTOR; BIOLOGICAL MARKER; HIGH MOBILITY GROUP PROTEIN; INSULIN LIKE GROWTH FACTOR BINDING PROTEIN RELATED PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-RELATED PROTEIN 1; MEMBRANE PROTEIN; PROSTATE SPECIFIC ANTIGEN; PSCA PROTEIN, HUMAN; PSCA PROTEIN, MOUSE; SOMATOMEDIN BINDING PROTEIN; SOX-9 TRANSCRIPTION FACTOR; TUMOR PROTEIN;

ANTIGEN SPECIFICITY; ARTICLE; CANCER INHIBITION; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DNA BINDING; DNA DETERMINATION; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GROWTH REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE TUMOR; SPINDLE CELL; TUMOR CELL LINE; ANIMAL; APOPTOSIS; CARCINOGEN TESTING; CELL CYCLE; CELL DIVISION; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY;

MUS MUSCULUS;

ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; CARCINOGENICITY TESTS; CELL CYCLE; CELL DIFFERENTIATION; CELL DIVISION; GENE EXPRESSION REGULATION, NEOPLASTIC; HIGH MOBILITY GROUP PROTEINS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, NUDE; NEOPLASM PROTEINS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; TRANSCRIPTION FACTORS;

EID: 3042670072     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207603     Document Type: Article

References (55)

1. Afonja O, Raaka BM, Huang A, Das S, Zhao X, Helmer E, Juste D and Samuels HH. (2002). Oncogene, 21, 7850-7860.
2. Bae VL, Jackson-Cook CK, Maygarden SJ, Plymate SR, Chen J and Ware JL. (1998). Prostate, 34, 275-282.
3. Bowles J and Koopman P. (2001). Genome Biol., 2, 10251-10254.
4. Burger A, Zhang X, Li H, Ostrowski J, Beatty B, Venanzoni M, Papas T and Seth A. (1997). Oncogene, 16, 2459-2467.
5. Chomczysnki P and Sacchi N. (1987). Anal. Biochem., 162, 156-159.
6. Clarkson MJ and Harley VR. (2002). Trends Endocrinol. Metab., 13, 106-111.
7. Damon SE, Maddison L, Ware JL and Plymate SR. (1998). Endocrinology, 139, 3456-3464.
8. Drivdahl RH, Sprenger CC, Trimm K and Plymate SR. (2001). Endocrinology, 142, 1990-1998.
9. Feinberg AP and Vogelstein B. (1983). Anal. Biochem., 132, 6-13.
10. Fourney RM, Day RS and Paterson MC. (1989). Focus, 10, 5-7.
11. Graff JR, Konicek BW, McNulty MN, Wang Z, Houck K, Allen S, Paul JD, Hbaiu A, Goode RG, Sandusky GF, Vessella RL and Neubauer BL. (2000). J. Biol. Chem., 275, 24500-24505.
12. Graves JA. (1998). BioEssays, 20, 264-269.
13. Healy C, Uwanogho D and Sharpe PT. (1999). Dev. Dyn., 215, 69-78.
14. Hossenlopp P, Seurin D, Segovia-Quinson B, Hardouin S and Binoux M. (1986). Anal. Biochem., 154, 138-143.
15. Hwa V, Tomasini-Sprenger C, Bermejo AB, Rosenfeld RG and Plymate SR. (1998). J. Clin. Endocinol., 83, 4355-4362.
16. Kanai Y and Koopman P. (1999). Hum. Mol. Genet., 8, 691-696.
17. Kato M, Sato H, Tsukada T, Ikawa Y, Aizawa S and Nagayoshi MA. (1996). Oncogene, 12, 1361-1364.
18. Kent J, Wheatley SC, Andrews JE, Sinclair AH and Koopman P. (1996). Development, 122, 2813-2822.
19. Kishibe J, Yamada S, Okada Y, Sato J, Ito A, Miyazaki K and Sugahara K. (2000). J. Biol. Chem., 275, 15321-15329.
20. Komatsu K, Okazaki Y, Tateno M, Kawai J, Konno H, Kusakabe K, Yoshiki A, Muramatsu M, Held WA and Hayashizaki Y. (2001). Biochem. Biophys. Res. Commun., 276, 109-117.
21. Koopman P, Bullejos M and Bowles J. (2001). J. Exp. Zool., 290, 463-474.
22. Lefebvre V, Huang W, Harley VR, Goodfellow PN and deCrombrugghe B. (1997). Mol. Cell. Biol., 17, 2336-2346.
23. Lehrach H, Diamond D, Wozney JM and Boedtker H. (1977). Biochemistry, 16, 4743-4749.
24. Li N, Oberley TD, Oberley LW and Zhong W. (1998). J. Cell. Physiol., 175, 359-369.
25. Lin HK, Yeh, Kang HY and Chang C. (2001). Proc. Natl. Acad. Sci. USA, 98, 7200-7205.
26. Lopez-Bermejo A, Buckway CK, Devi GR, Hwa V, Plymate SR, Oh Y and Rosenfeld RG. (2000). Endocrinology, 141, 4072-4080.
27. Lu S, Jenster G and Epner DE. (2000). Mol. Endocrinol., 14, 753-760.
28. Marshall OJ and Harley VR. (2000). Mol. Genet. Metab., 71, 455-462.
29. Miller GJ. (1999). Cancer Metastasis Rev., 17, 353-360.
30. Murakami S, Kan M, McKeehan WL and deCrombrugghe B. (2000). Proc. Natl. Acad. Sci. USA, 97, 1113-1118.
31. Murillo H, Huang H, Schmidt L, Smith DI and Tindall DJ. (2001). Endocrinology, 142, 4795-4805.
32. Murphy M, Pykett M, Harnish P, Zang K and George D. (1993). Cell Growth Differ., 4, 715-722.
33. Oberley LW. (2001). Antioxidants Redox Signal., 3, 461-472.
34. Oh Y, Nagalla S, Yamanaka Y, Kim H, Wilson E and Rosenfeld R. (1996). J. Biol. Chem., 271, 30322-30325.
35. Olney PN, Kean LS, Graham D, Elsas LJ and May KM. (1999). Am. J. Med. Genet., 84, 20-24.
36. Panda D, Miao D, Lefebvre V, Hendy G and Goltzman D. (2001). J. Biol. Chem., 276, 41229-41236.
37. Peehl DM and Stamey TA. (1986). In vitro Cell Dev., 22, 82-90.
38. Plymate SR, Haugk KH, Sprenger CC, Nelson PS, Tennant MK, Zhang Y, Oberley LW, Zhong W, Drivdahl RH and Oberley TD. (2003). Oncogene, 22, 1024-1034.
39. Preiss S, Argentaro A, Clayton A, John A, Jans D, Ogata T, Nagai T, Barroso I, Schafer A and Harley VR. (2001). J. Biol. Chem., 276, 27864-27872.
40. Reinikaninen P, Palvimo JJ and Janne OA. (1996). Endocrinology, 137, 4351-4357.
41. Rhee SG, Bae Y, Lee SR and Kwon J. (2000). Science Sign. Trans. Knowl. Environ., 53, 1-6.
42. Rosenthal DS, Ding R, Simbulan-Rosenthal CM, Vaillancourt JP, Nicholson DW and Smulson M. (1997). Exp. Cell Res., 232, 313-321.
43. Sambrook J, Fritsch EF and Maniatis T. (1989). Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory: Cold Spring Harbor, NY.
44. Simbulan-Rosenthal CM, Rosenthal D, Luo R and Smulson M. (1999). Mol. Cell. Biochem., 193, 137-148.
45. Spokony RF, Aoki Y, Saint-Germain N, Magner-Fink E and Saint-Jeannet JP. (2002). Development, 129, 421-432.
46. Sprenger CC, Damon SE, Hwa V, Rosenfeld RG and Plymate SR. (1999). Cancer Res., 59, 2370-2375.
47. Sprenger CC, Vail ME, Evans K, Smurdak J and Plymate SR. (2002). Oncogene, 21, 140-147.
48. Swisshelm K, Ryan K, Tsuchiya K and Sager R. (1995). Proc. Natl. Acad. Sci. USA, 92, 4472-4476.
49. Tran CP, Lin C, Yamashiro J and Reiter RE. (2002). Mol. Cancer Res., 1, 113-121.
50. Ulrich A, Berman CH, Dull TJ, Gray A and Lee JM. (1984). EMBO J., 3, 361-364.
51. Vidai VP, Chaboissier MC, Rooij DG and Schedl A. (2001). Nat. Genet., 28, 216-217.
52. Vleminckx K and Kemmler R. (1999). BioEssays, 21, 211-220.
53. Wilson EM, Oh Y, Hwa V and Rosenfeld RG. (2001). J. Clin. Endocrinol. Metab., 86, 4504-4511.
54. Wilson HMP, Birnbaum R, Poot M, Quinn LS and Swisshelm K. (2002). Cell Growth Differ., 13, 205-213.
55. Yeh S, Lin HK, Kang HY, Thin TH, Lin MF and Chang C. (1999). Proc. Natl. Acad. Sci. USA, 96, 5458-5463.